Babar Bashir

3.2k total citations
67 papers, 403 citations indexed

About

Babar Bashir is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Babar Bashir has authored 67 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Immunology. Recurrent topics in Babar Bashir's work include Cancer Immunotherapy and Biomarkers (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and CAR-T cell therapy research (9 papers). Babar Bashir is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and CAR-T cell therapy research (9 papers). Babar Bashir collaborates with scholars based in United States, United Kingdom and Canada. Babar Bashir's co-authors include Adam E. Snook, Walter K. Kraft, Douglas F. Stickle, Inna Chervoneva, Scott A. Waldman, Melissa Wilson, Jeffrey A. Rappaport, John C. Flickinger, Doron Schneider and Thomas M. Churilla and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Babar Bashir

59 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Babar Bashir United States 13 178 95 90 76 52 67 403
Hitomi Suzuki Japan 9 111 0.6× 117 1.2× 68 0.8× 99 1.3× 50 1.0× 43 459
Darlene J. Elias United States 13 106 0.6× 150 1.6× 78 0.9× 43 0.6× 72 1.4× 28 503
Lironne Wein Australia 6 214 1.2× 132 1.4× 87 1.0× 69 0.9× 49 0.9× 8 477
Tomoyuki Otsuka Japan 13 166 0.9× 116 1.2× 36 0.4× 170 2.2× 58 1.1× 66 541
Christina Guo United Kingdom 8 129 0.7× 111 1.2× 46 0.5× 167 2.2× 28 0.5× 26 350
Jie Peng China 13 115 0.6× 156 1.6× 45 0.5× 96 1.3× 18 0.3× 53 509
Alvaro Ingles Garces United Kingdom 13 200 1.1× 171 1.8× 66 0.7× 55 0.7× 42 0.8× 29 445
John L. Zapas United States 10 221 1.2× 69 0.7× 70 0.8× 53 0.7× 53 1.0× 23 381
Frank Seebach United States 9 166 0.9× 106 1.1× 59 0.7× 92 1.2× 80 1.5× 37 407

Countries citing papers authored by Babar Bashir

Since Specialization
Citations

This map shows the geographic impact of Babar Bashir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babar Bashir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babar Bashir more than expected).

Fields of papers citing papers by Babar Bashir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Babar Bashir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babar Bashir. The network helps show where Babar Bashir may publish in the future.

Co-authorship network of co-authors of Babar Bashir

This figure shows the co-authorship network connecting the top 25 collaborators of Babar Bashir. A scholar is included among the top collaborators of Babar Bashir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Babar Bashir. Babar Bashir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Anné, Pramila R., Karen Mooney, Maria Werner‐Wasik, et al.. (2024). Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. Radiation Oncology. 19(1). 65–65. 1 indexed citations
3.
McKean, Meredith, Òscar Reig, Elisa Fontana, et al.. (2024). 654P Peripheral neuropathy (PN) following treatment (tx) with bicycle toxin conjugates (BTCs) BT8009 or BT5528 monotherapy in patients (pts) with advanced solid tumors. Annals of Oncology. 35. S517–S517. 1 indexed citations
4.
Fontana, Emily, Meredith McKean, Raid Aljumaily, et al.. (2024). 647P EphA2-targeting bicycle toxin conjugate (BTC) BT5528 in patients (pts) with advanced solid tumors: A phase I/II study. Annals of Oncology. 35. S511–S512.
5.
Pronk, L., et al.. (2024). A phase I dose escalation study of the LRP5 antagonist BI 905681 in patients with advanced and metastatic solid tumors. ESMO Open. 9(11). 103730–103730. 4 indexed citations
7.
Bashir, Babar, See Kwok, Anthony S. Wierzbicki, et al.. (2023). Familial Chylomicronaemia Syndrome (FCS) Compared to Multifactorial Chylomicronaemia Syndrome (MCS) – Lessons learnt from United Kingdom FCS Registry. SHILAP Revista de lepidopterología. 54. S4–S4. 1 indexed citations
8.
Posey, James, Priscilla Machado, John R. Eisenbrey, et al.. (2023). Sonoporation for disrupting the pancreatic cancer microenvironment to enhance chemotherapy delivery and improve outcomes.. Journal of Clinical Oncology. 41(4_suppl). TPS777–TPS777. 1 indexed citations
9.
Luckett, Daniel J., Cesar A. Perez, Judy S. Wang, et al.. (2023). Abstract 921: Identification of NRG1 fusions in patients with solid tumors: analysis from a real-world community oncology network. Cancer Research. 83(7_Supplement). 921–921. 1 indexed citations
10.
Zheng, Richard, Babar Bashir, Charles J. Yeo, et al.. (2023). Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction. Clinical Journal of Gastroenterology. 16(3). 387–391. 1 indexed citations
11.
Bashir, Babar, et al.. (2022). Depression, anxiety and stress among healthcare workers in COVID-19 ICUs. Anaesthesia Pain & Intensive Care. 26(2). 217–223. 3 indexed citations
12.
Mansell, Holly, Ahmed Shoker, Jane Alcorn, et al.. (2022). Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients. Clinical and Translational Science. 15(7). 1687–1697. 3 indexed citations
13.
Subbiah, Suki, Jessica Y. Islam, Cassandra Hennessy, et al.. (2022). COVID-19 outcomes in patients with cancer and HIV: An analysis of the COVID-19 and Cancer Consortium (CCC19).. Journal of Clinical Oncology. 40(16_suppl). e18790–e18790. 1 indexed citations
14.
Bashir, Babar, et al.. (2021). Effectiveness of Non-Invasive vs. Invasive Ventilation in Acute Hypoxic Respiratory Failure in COVID-19 Patients in Critical Care: A Retrospective Cohort in Rahim Yar Khan, Pakistan. SHILAP Revista de lepidopterología. 60(2). 90–95.
15.
Flickinger, John C., et al.. (2021). GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert Review of Precision Medicine and Drug Development. 6(2). 117–129. 11 indexed citations
17.
Bashir, Babar & Melissa Wilson. (2019). Novel Immunotherapy Combinations. Current Oncology Reports. 21(11). 96–96. 12 indexed citations
18.
Bashir, Babar, et al.. (2014). Hemodialysis patients profile at Dow University of Health Sciences. Pakistan Journal of Medical Sciences. 30(6). 1327–30. 6 indexed citations
19.
Bashir, Babar, et al.. (2013). Acute Kidney Injury Secondary to Exposure to Insecticides Used for Bedbug (Cimex lectularis) Control. American Journal of Kidney Diseases. 62(5). 974–977. 12 indexed citations
20.
Mahboob, Amjad, et al.. (2011). EFFECT OF PREGNANCY ON THE DISEASE ACTIVITY IN ULCERATIVE COLITIS. Journal of Postgraduate Medical Institute. 25(4). 314–317. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026